Loading clinical trials...
Loading clinical trials...
This is a single-arm, open-label, multicenter, pivotal clinical trial to evaluate the efficacy and safety of brentuximab vedotin (SGN-35) as a single agent in patients with relapsed or refractory Hodg...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Seagen Inc.
Collaborators
NCT01196208 · Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, and more
NCT00649584 · Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, and more
University of Alabama at Birmingham
Birmingham, Alabama
City of Hope National Medical Center
Duarte, California
University of California at Los Angeles
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions